What is McKie Splints?
McKie Splints operates at the intersection of orthopedic medicine and biomechanical engineering, focusing on the design and production of therapeutic devices for the thumb, wrist, and hand. The company addresses critical needs for patients suffering from conditions ranging from arthritis and cerebral palsy to stroke-related impairments. By offering a comprehensive product suite that spans from infant to adult sizing, McKie Splints has established itself as a trusted partner for healthcare professionals and major medical institutions.
Beyond hardware, the company distinguishes itself through a commitment to clinical education. By providing webinars for occupational and physical therapy teams, McKie Splints ensures that its biomechanically designed neoprene and custom splints are utilized effectively to maximize hand functionality and patient independence.
How much funding has McKie Splints raised?
McKie Splints has raised a total of $26K across 1 funding round:
Debt
$26K
Debt (2021): $26K with participation from PPP
Key Investors in McKie Splints
PPP
Public-Private Partnership
What's next for McKie Splints?
With the recent influx of capital, McKie Splints is well-positioned to scale its manufacturing capabilities and expand its distribution network. The company's roadmap likely includes the development of next-generation materials to improve patient comfort and compliance, alongside an aggressive push to integrate its educational resources into more clinical training programs globally.
As the firm navigates this growth phase, the focus will remain on maintaining the high standards of medical efficacy that have defined its reputation. Future strategic initiatives will likely involve scaling the sales force to capture a larger share of the rehabilitation market and potentially exploring new therapeutic applications for its proprietary splinting technology.
